APA (7th ed.) Citation

Fang, W., Chen, Y., Nie, M., Zhou, X., Liu, Y., Tao, H., . . . Wang, X. Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation. MDPI AG.

Chicago Style (17th ed.) Citation

Fang, Wenxuan, Ying Chen, Mingyi Nie, Xuefeng Zhou, Yonghong Liu, Huaming Tao, Bin Yang, and Xueni Wang. Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation. MDPI AG.

MLA (9th ed.) Citation

Fang, Wenxuan, et al. Targeting YY1-DR5 Axis by Pyripyropene O as a Novel Therapeutic Strategy Against Prostate Cancer: Molecular Mechanisms and In Vivo Zebrafish Validation. MDPI AG.